about
Metabolic syndrome, diabetes, and cardiovascular risk in HIVMenopause-associated metabolic manifestations and symptomatology in HIV infection: a brief review with research implicationsHIV Infection in the Elderly: Arising ChallengesNutrition issues in chronic drug users living with HIV infection.Monocyte bioenergetic function is associated with body composition in virologically suppressed HIV-infected womenAdherence to the Mediterranean diet is associated with a lower risk of body-shape changes in Croatian patients treated with combination antiretroviral therapy.Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study.HIV-associated lipodystrophy: a review from a Brazilian perspectiveLack of association between stavudine exposure and lipoatrophy, dysglycaemia, hyperlactataemia and hypertriglyceridaemia: a prospective cross sectional studyIncreased aldosterone among HIV-infected women with visceral fat accumulationIn vitro and in vivo effects of IGF-I on adiposity in HIV-associated metabolic disease: a pilot studyAge-related skeletal muscle decline is similar in HIV-infected and uninfected individuals.HIV-associated lipodystrophy: impact of antiretroviral therapy.Combined use of waist and hip circumference to identify abdominally obese HIV-infected patients at increased health risk.Anthropometric differences between HIV-infected individuals prior to antiretroviral treatment and the general population from 1998-2007: the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) cohort and NHANES.Intermuscular and subcutaneous adipose tissue distributions differ in HIV+ versus HIV-men and womenAging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men.Comparison of dual-energy X-ray absorptiometry and magnetic resonance imaging-measured adipose tissue depots in HIV-infected and control subjects.Association of antiretroviral therapy with fibrinogen levels in HIV-infection.Regional anthropometry changes in antiretroviral-naïve persons initiating a Zidovudine-containing regimen in Mbarara, Uganda.Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM studyAssociation between hepatitis C virus coinfection and regional adipose tissue volume in HIV-infected men and women.HIV therapy, metabolic syndrome, and cardiovascular risk.Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factorsRelation of body composition to body mass index in HIV-infected patients with metabolic abnormalitiesGenes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.Growth hormone and tesamorelin in the management of HIV-associated lipodystrophyImpact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.Lipodystrophy in HIV patients: its challenges and management approaches.Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapyViral mechanisms of adipose dysfunction: lessons from HIV-1 VprRegional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophySerum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy.Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors.Relationship of fat distribution with adipokines in human immunodeficiency virus infection.The association between diet and physical activity on insulin resistance in the Women's Interagency HIV Study.Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093
P2860
Q26853470-72C1D574-3F56-4AD7-A77E-1BBBB0A45C4EQ26865187-63CB23D8-E986-4AF1-82B2-5755F087B654Q28076000-0482655F-3428-4E51-A217-ED8EE1048BB9Q33553170-FBE68D27-3022-4202-9DFD-58F6688686B7Q33555718-02C4ECD6-487A-4A8B-9FA2-014BCECD934AQ33752752-253C4CC2-3509-4913-9798-321D66B33BF7Q33927532-31813DC5-2FC3-4B27-A533-B14EB23BE930Q33939681-1F56990F-CF7C-4820-A8AC-BAAE7212A20AQ34039225-C5D2BD0F-CE72-4FE8-A578-64CE29236675Q34066641-10DE7E0E-596C-48F2-A916-2992339A75DBQ34522890-72CD9ADD-5173-420B-A2EC-F6DC831A3B9DQ34584634-795A21C7-E582-4ABB-8642-70597FE2E870Q34655845-9C5F7196-C3E3-42E6-877D-3F968E4D33A3Q34734960-855BA714-B96D-41D1-8D34-6CC11B3D3D21Q34766373-E2770E4D-2CB7-46DC-8213-8B3627323686Q35021199-01732D2D-ED39-4DC1-9E02-39CEEFF6F971Q35088160-1E18CF7F-B334-4B17-A372-8AAD35E92FD1Q35166131-7ED4E899-3EA9-4A25-AE9E-6ED785C98DADQ35166142-CA119E33-13A6-4886-9984-729262BCD1AAQ35166181-B3966D8D-F32D-4F9C-B5B9-A4948689F66CQ35173638-2C86DE4A-4F8B-402F-A533-9DD2911192DCQ35189974-60B61611-B455-4634-A257-CC22AD09CF77Q35189977-0858A14C-89F4-440F-9140-405A3667B207Q35194399-4413C650-459F-4F92-9D9D-6FE915E42CAAQ35206635-5FEB72E7-9ED0-4FED-8538-9FBA9C5A9870Q35369261-6B5DBE77-4C7C-45EA-966C-77C27367D8F5Q35535757-1F6C9F64-D0C7-46D9-A7D2-0977CFBD9C78Q35557342-BC1C14D4-F3D7-4526-A770-D16C5EB7EA9BQ35567828-7AE40393-C6A0-4D88-AC4A-29F3FBB97793Q35644326-D52BD430-CC37-4250-B667-49399F030936Q35671755-9EE02EEB-279C-4E38-BEC4-7839BC2B9E21Q35823452-CF53438D-A15F-4B36-A56D-653186005D68Q35834850-8B1B90F0-4F64-4F1D-9DFE-BF40BEA8B548Q35844759-9E8237CF-2BB8-4D9B-B70D-681C967DA2DFQ35979650-260566C3-2B23-4CD6-9ED5-FBB04A238F2EQ36206201-CA5ED399-36F3-43E7-93CC-1C157BF189ADQ36360789-3FFCFED7-2A0B-46D0-A35C-6A93B5A94615Q36487277-48E1D8D9-8DA8-4F9F-98A9-34231EA74684Q36687721-31FBE20F-78F2-4A81-B083-02C423E96B14Q36714041-6FBF6D9B-59FD-444C-B5EB-7C00874CF9FE
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Fat distribution in women with HIV infection.
@ast
Fat distribution in women with HIV infection.
@en
type
label
Fat distribution in women with HIV infection.
@ast
Fat distribution in women with HIV infection.
@en
prefLabel
Fat distribution in women with HIV infection.
@ast
Fat distribution in women with HIV infection.
@en
P2860
P1476
Fat distribution in women with HIV infection.
@en
P2093
Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM)
P2860
P304
P356
10.1097/01.QAI.0000229996.75116.DA
P407
P577
2006-08-01T00:00:00Z